Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01453946 · ClinicalTrials.gov registry record · Phase 3
Safety and Maintenance Study of Entocort for Children With Crohn's Disease
A Phase 3 study of Crohn's Disease, sponsored by Padagis.
- Completed
- Registry status
- Phase 3
- Development phase
- 55
- Enrollment target
- 19
- Study locations
NCT01453946: Completed Phase 3 study of Crohn's Disease, sponsored by Padagis.
NCT01453946 is a Phase 3 study of Crohn's Disease that has completed, run by Padagis. The registered enrollment target is 55 participants, below the 2,394-participant average among 105 other Crohn's Disease trials with a reported enrollment target (98% lower). The trial reports 19 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01453946, a Phase 3 study of Crohn's Disease, has completed, sponsored by Padagis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 55 participants
- Enrollment target
- 19
- Study locations
Study Summary
A Safety for Maintenance of Entocort EC for children with mild to moderate Crohn's Disease.
Primary Outcome
Any kind of adverse event
Conditions Studied
Interventions
- DRUG Entocort
Study Locations (19)
Other
- Research Site - München
- Research Site - Nuremberg
- Research Site - Florence
- Research Site - Messina
- Research Site - Roma
- Research Site - Krakow
- Research Site - Lodz
- Research Site - Rzeszów
- Research Site - Warsaw
- Research Site - Wroclaw
Georgia
- Research Site - Atlanta
Illinois
- Research Site - Oak Lawn
Massachusetts
- Research Site - Newton
Minnesota
- Research Site - Saint Paul
New Jersey
- Research Site - Mays Landing
New York
- Research Site - Buffalo
Texas
- Research Site - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-02 |
| Phase | Phase 3 |
What the finished NCT01453946 record still lists
NCT01453946 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 2,394-participant average among 105 other Crohn's Disease trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Crohn's Disease appearing as the primary indexed condition, and to 1 intervention - of which Entocort is the first listed.
NCT01453946 lists 19 locations in 10 states (Other, Georgia, Illinois).
Frequently Asked Questions
What is clinical trial NCT01453946 about?
NCT01453946 is a clinical study titled "Safety and Maintenance Study of Entocort for Children With Crohn's Disease". A Safety for Maintenance of Entocort EC for children with mild to moderate Crohn's Disease.
What is the current status of trial NCT01453946?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 55 participants. The study started on 2011-12. Estimated completion is 2014-02.
What conditions does trial NCT01453946 study?
This clinical trial studies the following conditions: Crohn's Disease.
What interventions are being tested in trial NCT01453946?
The interventions under investigation include: Entocort (DRUG).
Who is sponsoring clinical trial NCT01453946?
This trial is sponsored by Padagis, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01453946 being conducted?
This trial has 19 study locations across Georgia, Illinois, Massachusetts, Minnesota, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Crohn's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01453946's enrollment target sits among peer trials
55 81st of 105 higher than 25 of 105 other Crohn's Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Crohn's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
RECRUITING · Phase 3
-
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
RECRUITING · Phase 3
-
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
RECRUITING · Phase 3
-
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
RECRUITING · Phase 3
-
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
RECRUITING · Phase 3
-
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia